As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
We are delighted to announce Borderline Personality Disorder and Emotion Dysregulation' first Impact Factor is 2.067! The journal is also indexed in Scopus and PubMed. Submit your article now!
COVID-19 and impact on peer review
Aims and scope
Borderline Personality Disorder and Emotion Dysregulation provides a platform for researchers and clinicians interested in borderline personality disorder (BPD) as a currently highly challenging psychiatric disorder. Emotion dysregulation is at the core of BPD but also stands on its own as a major pathological component of the underlying neurobiology of various other psychiatric disorders. The journal focuses on the psychological, social and neurobiological aspects of emotion dysregulation as well as epidemiology, phenomenology, pathophysiology, treatment, neurobiology, genetics, and animal models of BPD. Contributions investigating the broad field of emotion regulation and dysregulation as well as related pathological mechanisms such as dysfunctional self-concepts and dysfunctional social interaction are welcomed, as are studies of novel treatments for BPD. In addition, the journal considers research into the frequent, co-occurring psychiatric disorders like Post-traumatic Stress Disorder, ADHD, depression, eating disorders, conduct disorders, drug abuse, and social phobia.
Latest article collection
ADHD and BPD - associated, but poorly understood
Edited by Alexandra Philipsen
Announcing the launch of In Review
Borderline Personality Disorder and Emotion Dysregulation, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
- Share their work with fellow researchers to read, comment on, and cite even before publication
- Showcase their work to funders and others with a citable DOI while it is still under review
- Track their manuscript - including seeing when reviewers are invited, and when reports are received
Sections in BPDED
Borderline Personality Disorder and Emotion Dysregulation is proud to present the following sections, edited by experts in each field. These sections don't represent the full scope of the journal, but provide additional focus on areas outside our primary focuses of emotion dysregulation and BPD.
BPDED is the official journal of the European Society for the Study of Personality Disorders. The ESSPD stimulates and supports scholarship, clinical experience, international collaboration and communication of research on all aspects of personality disorders including epidemiology, etiology, diagnosis and assessment, course and treatment in Europe. For more information on the ESSPD, please visit their landing page.
Borderline Personality Disorder and Emotion Dysregulation is the official journal of the Dachverband Dialektisch Behaviorale Therapie (DDBT) and the National Education Alliance for Borderline Personality Disorder (NEA.BPD). For further information on the DDBT, visit their website here
The National Education Alliance for Borderline Personality Disorder (NEA.BPD) is a 501 (c)(3) non-profit organization established in 2001 by four family members, two consumers and one mental health professional. An internationally recognized organization, NEA.BPD is dedicated to building lives for millions of people affected by borderline personality disorder (BPD). To find out more about the NEA.BPD, visit their website here.
Martin Bohus is the Medical Director at the Central Institute of Mental Health and has held the position of the Chair of Psychosomatic Medicine and Psychotherapy, Heidelberg University since 2003. Dr. Bohus received his M.D. at Freiburg Medical School and did his residency in Psychiatry and Neurology at Freiburg Medical School. He made his specialty in Psychiatry and Psychotherapy and in Psychosomatic Medicine. He has received several awards for psychotherapy research. He is a Board Member of the German Association of Psychiatry (DGPPN), Vice President of the European Society for the Studies of Personality Disorders (ESSPD), President of the German Association for DBT and co-Chair of the International Strategic Planning Meeting for Dialectical Behavior Therapy (SPM). He was President and Initiator: 1st International Congress on Borderline Personality Disorder, Berlin 2010 and since 2012 he is a Spokesperson of the Clinical Research Unit “Mechanisms of Disturbed Emotion Processing in BPD”. He has currently published 220 articles and book chapters, mainly on borderline personality disorders.
John M. Oldham, M.D. is currently Distinguished Emeritus Professor in the Department of Psychiatry and Behavioral Sciences at Baylor College of Medicine in Houston, Texas, USA. He previously held the Barbara and Corbin J Robertson, Jr Endowed Chair for Personality Disorders and served as Senior Vice President and Chief of Staff of the Menninger Clinic. Earlier in his career, Dr. Oldham was Director of the New York State Psychiatric Institute, Chief Medical Officer of the New York State Office of Mental Health, and the Elizabeth K. Dollard Professor and Acting Chairman of the Department of Psychiatry, Columbia University College of Physicians and Surgeons. In 2002, Dr. Oldham became Professor and Chairman of the Department of Psychiatry and Behavioral Sciences and Executive Director of the Institute of Psychiatry at the Medical University of South Carolina, and he relocated to Houston in 2007. Dr. Oldham is the Past President of the American Psychiatric Association, Past President of the American College of Psychiatrists, Past President of the New York County District Branch of the American Psychiatric Association, Past President of the South Carolina Psychiatric Association, Past President of the International Society for the Study of Personality Disorders, and Past President of the Association for Research on Personality Disorders.
Christian Schmahl is Medical Director of the Department of Psychosomatic Medicine and Psychotherapy, Central Institute of Mental Health, Mannheim and spokesperson of the Clinical Research Unit “Mechanisms of Disturbed Emotion Processing in Borderline Personality Disorder”. Dr Schmahl received his M.D. at Giessen Medical School and did his residency in Psychiatry at Freiburg Medical School. He spent a one-year research fellowship at Yale and Emory University mentored by J. D. Bremner, M.D. with a training in neuroimaging. In 2003 he received a Young Investigator Award of the Borderline Personality Disorder Research Foundation, in 2004 he received the Young Investigator's Award of the National Education Alliance for Borderline Personality Disorder, in 2005 the First Prize for Pain Research of the German Society for the Study of Pain, and in 2007 Young Researchers Award of the International Society for the Study of Personality Disorders”. He has published more than 100 articles and book chapters.
Annual Journal Metrics
53 days to first decision for reviewed manuscripts only
48 days to first decision for all manuscripts
111 days from submission to acceptance
35 days from acceptance to publication
2.067 - 2-year Impact Factor
176 Altmetric mentions